Identification and characterization by LC-UV-MS/MS of melanotan II skin-tanning products sold illegally on the Internet

被引:19
作者
Breindahl, Torben [1 ]
Evans-Brown, Michael [2 ]
Hindersson, Peter [1 ]
McVeigh, Jim [3 ]
Bellis, Mark [3 ]
Stensballe, Allan [4 ]
Kimergard, Andreas [3 ]
机构
[1] Aalborg Univ, Dept Clin Biochem, Vendsyssel Hosp, DK-9800 Hjorring, Denmark
[2] European Monitoring Ctr Drugs & Drug Addict, Lisbon, Portugal
[3] Liverpool John Moores Univ, Ctr Publ Hlth, Liverpool L3 5UX, Merseyside, England
[4] Aalborg Univ, Dept Hlth Sci & Technol, DK-9800 Hjorring, Denmark
关键词
melanotan II; liquid chromatography; tandem mass spectrometry; identification; assay; impurities; LIQUID-CHROMATOGRAPHIC ASSAY; PENILE ERECTION; PEPTIDE; PIGMENTATION; PLASMA; ANALOG; MEN;
D O I
10.1002/dta.1655
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
New methods were developed and validated to determine the identity, contents, and purity of samples of melanotan II, a synthetic melanocortin receptor agonist, sold in vials as injectable skin-tanning products that were purchased from three online shops. Methods were based on liquid chromatography with ultra-violet detection (LC-UV) at wavelength 218 nm, and tandem mass spectrometric detection (MS/MS) after collision-induced fragmentation of the double charged [M+2H](2+) precursor ion (m/z 513). Identification of melanotan II was verified by correct chromatographic retention time, and relative abundance ratios of five qualifying fragment ions. LC-UV was used to quantify melanotan II as well as impurities. Method validation was performed with reference to guidelines for assessing active substances in authorized medicinal products to reach acceptable accuracy and precision. Vials from two shops contained unknown impurities ranging from 4.1 to 5.9%; impurities from one shop were below the quantification limit. The total amount of melanotan II in vials ranged between 4.32 and 8.84 mg, although each shop claimed that vials contained 10 mg melanotan II. A broad range of drugs used for enhancement purposes can be obtained from the illicit market. However, users of these drugs may be exposed to a range of potential harms, as shown in this study, given that these products are manufactured, distributed and supplied from an illicit market. Copyright (c) 2014 John Wiley & Sons, Ltd.
引用
收藏
页码:164 / 172
页数:9
相关论文
共 43 条
[1]  
[Anonymous], 1994, VAL AN PROC TEXT MET, VQ2
[2]  
[Anonymous], 2011, SEARCH ENGINE OPTIMI
[3]   [Nle4-D-Phe7]-α-melanocyte-stimulating hormone significantly increased pigmentation and decreased UV damage in fair-skinned Caucasian volunteers [J].
Barnetson, Ross StC. ;
Ooi, Terry K. T. ;
Zhuang, Liqing ;
Halliday, Gary M. ;
Reid, Catherine M. ;
Walker, Patrick C. ;
Humphrey, Stuart M. ;
Kleinig, Michael J. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (08) :1869-1878
[4]  
Breindahl T., 2010, DANSK KEMI, V91, P14
[5]  
Burian Ewa, 2013, Lakartidningen, V110, P208
[6]  
Danish Health and Medicines Authority, 2008, WARN PROD MEL
[7]   Effects of a superpotent melanotropic peptide in combination with solar UV radiation on tanning of the skin in human volunteers [J].
Dorr, RT ;
Ertl, G ;
Levine, N ;
Brooks, C ;
Bangert, JL ;
Powell, MB ;
Humphrey, S ;
Alberts, DS .
ARCHIVES OF DERMATOLOGY, 2004, 140 (07) :827-835
[8]   Evaluation of Melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study [J].
Dorr, RT ;
Lines, R ;
Levine, N ;
Brooks, C ;
Xiang, L ;
Hruby, VJ ;
Hadley, ME .
LIFE SCIENCES, 1996, 58 (20) :1777-1784
[9]  
Evans-Brown M., 2012, Human enhancement drugs: The emerging challenges to public health
[10]   Use of melanotan I and II in the general population [J].
Evans-Brown, Michael ;
Dawson, Rob T. ;
Chandler, Martin ;
McVeigh, Jim .
BRITISH MEDICAL JOURNAL, 2009, 338